Page 38 - Zai Lab News Today

Chinese online tutoring start-up Yuanfudao has announced an AI-powered UI design tool called Motiff, scheduled to launch later this year.

A combination of toripalimab and perioperative chemotherapy significantly extended EFS compared with chemotherapy alone among patients with resectable stage III non-small cell lung cancer, according to results of a randomized phase 3 study.The findings of the Neotorch study, presented during an ASCO Plenary Series session, also showed the addition of toripalimab (Junshi Biosciences) to

Company to Host Conference Call and Webcast on May 10, 2023, at 8:00 a.m. ETSHANGHAI, China and CAMBRIDGE, Mass., April 20, 2023 -- Zai Lab Limited today announced that it will report financial... | April 20, 2023

By Raghav Mahobe and Sriparna Roy (Reuters) - A panel of U.S. Food and Drug Administration advisers on Monday unanimously voted in favor of Innoviva I...

By Raghav Mahobe and Sriparna Roy (Reuters) - A panel of U.S. Food and Drug Administration advisers on Monday unanimously voted in favor of Innoviva I...

The panel on Monday unanimously voted in favor of Innovivas experimental antibiotic in the treatment of serious bacterial infections, typically associated with hospitalizations, the company said.

Yesterday Amazon launched Bedrock for generative AI, escalating the cloud AI wars that have been heating up over the past year.

The Dubai Museum of the Future will host the annual international ‘Machines Can See’ summit to explore the future of computer vision and machine learning.

/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...

Angle PLC Announces Pharma Services Contract with Crescendo Biologics